Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice

Svetlana P. Chapoval, Eric V. Marietta, Michele K. Smart, Chella S. David

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Airway inflammation is central to the pathogenesis of allergic asthma, and molecules that mediate this process obviously represent targets for therapy. Objective: To study the role of CD4+ T cells and/or HLA-DQ molecules in allergic asthma, we have generated and characterized models of short ragweed allergen (SRW)-induced inflammation using transgenic mice with HLA-DQ (DQ6 or DQ8), human CD4 (hCD4), or both on a genetic background that lacks mouse MHC II and CD4 (Aβ0/mCD40). Methods: Mice were actively sensitized and later challenged intranasally with SRW allergenic extract. Bronchoalveolar lavage fluid composition, airway inflammation and hyperresponsiveness, blood eosinophil levels, and cell proliferation were examined. Results: In response to SRW treatment, both DQ6 and DQ8 transgenic mice expressing hCD4 developed pulmonary eosinophilia and associated lung tissue damage with increase in eosinophil peroxidase and TH2 cytokines in bronchoalveolar lavage fluid, strong airway hyperreactivity, and persistent blood eosinophilia. The response was independent of mast cells/histamine pathway and was mediated by DQ-restricted hCD4+ T cells. Interestingly, lungs of CD4-deficient DQ6 transgenic mice showed an eosinophilic inflammation without local increase in cytokines and eosinophil peroxidase. The allergic reaction was absent in double-knockout mice and mice expressing either DQ8 or hCD4 alone. Conclusions: DQ6 molecules are critical to SRW-induced allergy and can operate in the presence or absence of CD4. However, both DQ antigens and CD4 molecules are critical for full manifestation of allergen-induced asthma in transgenic mice.

Original languageEnglish (US)
Pages (from-to)764-771
Number of pages8
JournalJournal of Allergy and Clinical Immunology
Volume108
Issue number5
DOIs
StatePublished - 2001

Fingerprint

HLA-DQ Antigens
Ambrosia
Allergens
Transgenic Mice
Inflammation
Eosinophil Peroxidase
Asthma
Bronchoalveolar Lavage Fluid
Hypersensitivity
Pulmonary Eosinophilia
Cytokines
T-Lymphocytes
Lung
CD4 Antigens
Eosinophilia
Eosinophils
Knockout Mice
Mast Cells
Histamine
Cell Proliferation

Keywords

  • Asthma
  • HLA
  • Human CD4
  • In vivo animal models
  • MHC
  • Short ragweed allergen
  • Transgenic/knockout

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice. / Chapoval, Svetlana P.; Marietta, Eric V.; Smart, Michele K.; David, Chella S.

In: Journal of Allergy and Clinical Immunology, Vol. 108, No. 5, 2001, p. 764-771.

Research output: Contribution to journalArticle

Chapoval, Svetlana P. ; Marietta, Eric V. ; Smart, Michele K. ; David, Chella S. / Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice. In: Journal of Allergy and Clinical Immunology. 2001 ; Vol. 108, No. 5. pp. 764-771.
@article{6873195901fe4c419c3a6da4a5e4ead7,
title = "Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice",
abstract = "Background: Airway inflammation is central to the pathogenesis of allergic asthma, and molecules that mediate this process obviously represent targets for therapy. Objective: To study the role of CD4+ T cells and/or HLA-DQ molecules in allergic asthma, we have generated and characterized models of short ragweed allergen (SRW)-induced inflammation using transgenic mice with HLA-DQ (DQ6 or DQ8), human CD4 (hCD4), or both on a genetic background that lacks mouse MHC II and CD4 (Aβ0/mCD40). Methods: Mice were actively sensitized and later challenged intranasally with SRW allergenic extract. Bronchoalveolar lavage fluid composition, airway inflammation and hyperresponsiveness, blood eosinophil levels, and cell proliferation were examined. Results: In response to SRW treatment, both DQ6 and DQ8 transgenic mice expressing hCD4 developed pulmonary eosinophilia and associated lung tissue damage with increase in eosinophil peroxidase and TH2 cytokines in bronchoalveolar lavage fluid, strong airway hyperreactivity, and persistent blood eosinophilia. The response was independent of mast cells/histamine pathway and was mediated by DQ-restricted hCD4+ T cells. Interestingly, lungs of CD4-deficient DQ6 transgenic mice showed an eosinophilic inflammation without local increase in cytokines and eosinophil peroxidase. The allergic reaction was absent in double-knockout mice and mice expressing either DQ8 or hCD4 alone. Conclusions: DQ6 molecules are critical to SRW-induced allergy and can operate in the presence or absence of CD4. However, both DQ antigens and CD4 molecules are critical for full manifestation of allergen-induced asthma in transgenic mice.",
keywords = "Asthma, HLA, Human CD4, In vivo animal models, MHC, Short ragweed allergen, Transgenic/knockout",
author = "Chapoval, {Svetlana P.} and Marietta, {Eric V.} and Smart, {Michele K.} and David, {Chella S.}",
year = "2001",
doi = "10.1067/mai.2001.118794",
language = "English (US)",
volume = "108",
pages = "764--771",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice

AU - Chapoval, Svetlana P.

AU - Marietta, Eric V.

AU - Smart, Michele K.

AU - David, Chella S.

PY - 2001

Y1 - 2001

N2 - Background: Airway inflammation is central to the pathogenesis of allergic asthma, and molecules that mediate this process obviously represent targets for therapy. Objective: To study the role of CD4+ T cells and/or HLA-DQ molecules in allergic asthma, we have generated and characterized models of short ragweed allergen (SRW)-induced inflammation using transgenic mice with HLA-DQ (DQ6 or DQ8), human CD4 (hCD4), or both on a genetic background that lacks mouse MHC II and CD4 (Aβ0/mCD40). Methods: Mice were actively sensitized and later challenged intranasally with SRW allergenic extract. Bronchoalveolar lavage fluid composition, airway inflammation and hyperresponsiveness, blood eosinophil levels, and cell proliferation were examined. Results: In response to SRW treatment, both DQ6 and DQ8 transgenic mice expressing hCD4 developed pulmonary eosinophilia and associated lung tissue damage with increase in eosinophil peroxidase and TH2 cytokines in bronchoalveolar lavage fluid, strong airway hyperreactivity, and persistent blood eosinophilia. The response was independent of mast cells/histamine pathway and was mediated by DQ-restricted hCD4+ T cells. Interestingly, lungs of CD4-deficient DQ6 transgenic mice showed an eosinophilic inflammation without local increase in cytokines and eosinophil peroxidase. The allergic reaction was absent in double-knockout mice and mice expressing either DQ8 or hCD4 alone. Conclusions: DQ6 molecules are critical to SRW-induced allergy and can operate in the presence or absence of CD4. However, both DQ antigens and CD4 molecules are critical for full manifestation of allergen-induced asthma in transgenic mice.

AB - Background: Airway inflammation is central to the pathogenesis of allergic asthma, and molecules that mediate this process obviously represent targets for therapy. Objective: To study the role of CD4+ T cells and/or HLA-DQ molecules in allergic asthma, we have generated and characterized models of short ragweed allergen (SRW)-induced inflammation using transgenic mice with HLA-DQ (DQ6 or DQ8), human CD4 (hCD4), or both on a genetic background that lacks mouse MHC II and CD4 (Aβ0/mCD40). Methods: Mice were actively sensitized and later challenged intranasally with SRW allergenic extract. Bronchoalveolar lavage fluid composition, airway inflammation and hyperresponsiveness, blood eosinophil levels, and cell proliferation were examined. Results: In response to SRW treatment, both DQ6 and DQ8 transgenic mice expressing hCD4 developed pulmonary eosinophilia and associated lung tissue damage with increase in eosinophil peroxidase and TH2 cytokines in bronchoalveolar lavage fluid, strong airway hyperreactivity, and persistent blood eosinophilia. The response was independent of mast cells/histamine pathway and was mediated by DQ-restricted hCD4+ T cells. Interestingly, lungs of CD4-deficient DQ6 transgenic mice showed an eosinophilic inflammation without local increase in cytokines and eosinophil peroxidase. The allergic reaction was absent in double-knockout mice and mice expressing either DQ8 or hCD4 alone. Conclusions: DQ6 molecules are critical to SRW-induced allergy and can operate in the presence or absence of CD4. However, both DQ antigens and CD4 molecules are critical for full manifestation of allergen-induced asthma in transgenic mice.

KW - Asthma

KW - HLA

KW - Human CD4

KW - In vivo animal models

KW - MHC

KW - Short ragweed allergen

KW - Transgenic/knockout

UR - http://www.scopus.com/inward/record.url?scp=0035190416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035190416&partnerID=8YFLogxK

U2 - 10.1067/mai.2001.118794

DO - 10.1067/mai.2001.118794

M3 - Article

VL - 108

SP - 764

EP - 771

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5

ER -